CLASS II Drug recall · Reported 30 Mar 2022 · FDA Enforcement Report

Sincalide Lyophilized powder recalled by Olympia Compounding Pharmacy

Olympia Compounding Pharmacy is recalling Sincalide Lyophilized powder for reconstitution Each ML contains: Mannitol 170mg, distributed nationwide in the US. The recall was initiated on 8 Mar 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: D24001 Exp. 4/1/22
Quantity recalled836 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0724-2022
FDA event ID
89717
Recalling firm
Olympia Compounding Pharmacy, Orlando, FL
Classification
Class II
Status
Terminated
Recall initiated
8 Mar 2022
FDA classified
29 Mar 2022
Reported
30 Mar 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

8 Mar 2022Recall initiated by company
29 Mar 2022Classified by FDA+21 days
30 Mar 2022Published in enforcement report+1 day

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Super Potent and Failed Reconstitution Time

Product as listed by the FDA

Sincalide Lyophilized powder for reconstitution Each ML contains: Mannitol 170mg, Arginine 30mg, Lysine 15mg, Potassium Phosphate 9mg, Methionine 4mg, Edetate Disodium Dihydrate 2mg, Polysorbate mcg, Water for Injection, Multiple Dose Injection 5 mcg Vial, Rx Only, Olympia Compounding Pharmacy Compounded by: Olympia Pharmacy Conroy Rd., Ste. 155, Orlando, FL 32835, NDC 73198-0082-00 Revised Label: Sincalide Lyophilized powder for reconstitution, 5mcg per multi dose vial, Each ML contains: 16.7% Mannitol, 3% Arginine, 1.5% Lysine, 0.9% Potassium Phosphate, 0.4% Methionine, 0.2% Edetate Disodium Dihydrate, 0.004% Sodium Metabisulfate, 0.0005% Polysorbate. Water for injection. Rx only, Olympia Pharmaceuticals NDC 73198-0082-00

Where it was distributed

Nationwide in the USA including Puerto Rico.

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Super Potent and Failed Reconstitution Time

Which lots are affected?

Lot: D24001 Exp. 4/1/22

Where was it sold?

Nationwide in the USA including Puerto Rico.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

6 other products · FDA event 89717

This product is part of a recall event; the main page for the event is Sermorelin Acetate Lyophilized powder for reconstitution recalled.

More recalls from Olympia Compounding Pharmacy

All 94